Klinikum der Ludwig-Maximilians-Universität München

München 81377

0 studies enrolling now · 2 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Indolent Non-Hodgkin's Lymphomas, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early